Bromide

Bromide

SCHEMBL8906290

Br.Nc1c(O)ccc2c1CNCC2c1ccc(O)c(O)c1

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.71
MAPK1 P28482 2/20 0.58
LMNA P02545 2/20 0.58
KDM4E B2RXH2 2/20 0.58
ALDH1A1 P00352 2/20 0.58
MAPT P10636 2/20 0.58
PMP22 Q01453 2/20 0.58
HPGD P15428 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
TAAR1 Q96RJ0 1/20 0.58
CYP3A4 P08684 1/20 0.56
ALOX15 P16050 1/20 0.56
TSHR P16473 1/20 0.56
NFKB1 P19838 1/20 0.56
THPO P40225 1/20 0.56
HSD17B10 Q99714 1/20 0.56
KIF11 P52732 1/20 0.39
QDPR P09417 1/20 0.39
DRD1 P21728 3/20 0.37
ADCY5 O95622 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL11274798 0.86 PARP1 (0.76) PARP1MAPK1LMNAKDM4EALDH1A1
Bromide SCHEMBL11266282 0.86 PARP1 (0.76) PARP1MAPK1LMNAKDM4EALDH1A1
Zelandopam SCHEMBL8904601 0.86 PARP1 (0.74) PARP1MAPK1LMNAKDM4EALDH1A1
Bromide SCHEMBL11102755 0.84 PARP1 (0.97) PARP1MAPK1LMNAKDM4EALDH1A1
Zelandopam SCHEMBL8904866 0.84 PARP1 (0.72) PARP1MAPK1LMNAKDM4EALDH1A1
Zelandopam SCHEMBL8904713 0.84 PARP1 (0.72) PARP1MAPK1LMNAKDM4EALDH1A1
Zelandopam SCHEMBL8904707 0.84 PARP1 (0.72) PARP1MAPK1LMNAKDM4EALDH1A1
Zelandopam SCHEMBL9667773 0.84 PARP1 (0.76) PARP1MAPK1LMNAKDM4EALDH1A1
Zelandopam SCHEMBL29388489 0.84 PARP1 (0.76) PARP1MAPK1LMNAKDM4EALDH1A1
Zelandopam SCHEMBL18311503 0.84 PARP1 (0.76) PARP1MAPK1LMNAKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5623074-A DERIVATIVES OF 7-DIHYDROXYPHENYL-4,5,6,7-TETRAHYDROTHIAZOLO (4,5-C)PYRIDINE WHICH ACT ON DOPAMINE RECEPTORS; NEPHROVASCULAR DILATORS, DIURETICS, SIDE EFFECT REDUCTION YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1997-04-22 US disclosed
US-5378849-A Kidney vasodilators; orally administered YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1995-01-03 US disclosed
US-5204468-A Nephrovascular dilators and diuretics; side effect reduction; administered by mouth YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1993-04-20 US disclosed
US-5079256-A Administering to treat diseases of circulatory organs such as renal/cardiac insufficiency YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1992-01-07 US disclosed
US-5077406-A Cyclization, deprotecting and salt formation YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1991-12-31 US disclosed
US-4966904-A DILUROGENITAL DISORDERS; DILATION OF NEOPHROVASCULAR TRACTS YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1990-10-30 US disclosed
US-4876261-A UROGENITAL DISORDERS; NEPHROVASCULAR DILATORS; ACT ON DOPAMINE RECEPTOR YAMANOUCHI PHARMACEUTICAL CO., LTD. 1989-10-24 US disclosed